| P50 | author | Ruth J McQuitty | Q59989904 |
| | Ana M Pizarro | Q39639976 |
| P2093 | author name string | Peter J Sadler | |
| | Yao Zhao | |
| | Julie A Woods | |
| | Fiona S Mackay | |
| P2860 | cites work | Cytotoxicity, hydrophobicity, uptake, and distribution of osmium(II) anticancer complexes in ovarian cancer cells | Q39765073 |
| | Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine. | Q40018355 |
| | A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin | Q40318101 |
| | Synthesis and characterization of platinum(IV) anticancer drugs with functionalized aromatic carboxylate ligands: influence of the ligands on drug efficacies and uptake | Q40342527 |
| | The mechanism of action of platinum(IV) complexes in ovarian cancer cell lines | Q40509008 |
| | Cellular accumulation of the anticancer agent cisplatin: a review | Q40917698 |
| | Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5'-GMP)platinum(II) amine adducts | Q41364994 |
| | Glutathione-mediated activation of anticancer platinum(IV) complexes | Q42220365 |
| | The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae | Q44187748 |
| | Synthesis and cytotoxicity of new platinum(IV) complexes of mixed carboxylates | Q44530731 |
| | Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes. | Q46569102 |
| | Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake | Q46978418 |
| | Distinct mechanisms for Ctr1-mediated copper and cisplatin transport. | Q52580418 |
| | Modifying the structure of dinuclear ruthenium complexes with antitumor activity | Q56851335 |
| | Antiproliferative Pt(IV) complexes: synthesis, biological activity, and quantitative structure–activity relationship modeling | Q57819324 |
| | An Updated View of Cisplatin Transport | Q59172334 |
| | Mechanistic insight into the cellular uptake and processing of cisplatin 30 years after its approval by FDA | Q59172508 |
| | Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA | Q70799278 |
| | Preclinical characterization of anticancer gallium(III) complexes: solubility, stability, lipophilicity and binding to serum proteins | Q80179935 |
| | Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells | Q84922665 |
| | Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile | Q24625759 |
| | On the Use of 1H and 13C 1D NMR Spectra as QSPR Descriptors | Q27134659 |
| | Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings | Q27861111 |
| | The status of platinum anticancer drugs in the clinic and in clinical trials | Q28286605 |
| | Cellular processing of platinum anticancer drugs | Q29617899 |
| | Insights into the acid-base properties of Pt(IV)-diazidodiam(m)inedihyroxido complexes from multinuclear NMR spectroscopy | Q30450733 |
| | Enhancing tumor-specific uptake of the anticancer drug cisplatin with a copper chelator | Q33986172 |
| | Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers | Q34105902 |
| | Photoactivated chemotherapy (PACT): the potential of excited-state d-block metals in medicine. | Q34105908 |
| | Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution. | Q34328742 |
| | Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals | Q34393336 |
| | Conformation and recognition of DNA modified by a new antitumor dinuclear PtII complex resistant to decomposition by sulfur nucleophiles. | Q34803055 |
| | Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs | Q35454498 |
| | Metal transport across biomembranes: emerging models for a distinct chemistry. | Q35922313 |
| | Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes | Q35994695 |
| | Relationships between hydrophobicity, reactivity, accumulation and peripheral nerve toxicity of a series of platinum drugs | Q36641336 |
| | A potent cytotoxic photoactivated platinum complex | Q36696320 |
| | Direct cellular responses to platinum-induced DNA damage | Q36800400 |
| | A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells | Q36852560 |
| | Role of copper transporters in resistance to platinating agents | Q37323536 |
| | Inhibition of transcription by platinum antitumor compounds | Q37364815 |
| | Platinum drug distribution in cancer cells and tumors | Q37587977 |
| | Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. | Q38315077 |
| | Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds. | Q39473654 |
| | Organometallic half-sandwich iridium anticancer complexes. | Q39569475 |
| | Studies on Cellular Accumulation of Satraplatin and Its Major Metabolite JM118 and Their Interactions with Glutathione | Q39645840 |
| | A potent trans-diimine platinum anticancer complex photoactivated by visible light. | Q39672784 |
| P433 | issue | 6 | |
| P304 | page(s) | 1169-1175 | |
| P577 | publication date | 2014-05-19 | |
| P1433 | published in | ChemMedChem | Q2962252 |
| P1476 | title | Cellular accumulation, lipophilicity and photocytotoxicity of diazido platinum(IV) anticancer complexes | |
| P478 | volume | 9 | |